Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 0.000p
  • 52 Week Low: 0.000p
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 0

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Huw Jones 3,184,793 £0
Toni Hänninen 1,000,000 £0

Major Shareholders

Notifier** Holding Value*
Northern Standard Limited 422,727,272 £0
TRACARTA LIMITED 422,727,272 £0
First Equity Limited 179,000,000 £0
T and I Limited 160,000,000 £0
Oberon Investments Limited 80,475,000 £0
Spreadex Ltd 80,009,545 £0
Andrew Leach 80,000,000 £0
Simon Gibeon 71,400,000 £0
Rathbones Investment Management Ltd 25,789,246 £0
Sarum Investment SICAV Plc 25,700,000 £0
Octopus Investments Nominees Limited 21,875,000 £0
Octopus Investments Nominees Limited 21,875,000 £0
Vulpes Investment Management Pte Ltd 20,554,191 £0
InterTrader Limited 16,560,033 £0
Seneca Partners Limited 16,301,456 £0
North West Fund (Biomedical) LP 16,186,446 £0
Richard Griffiths and family 14,408,000 £0
AXA Framlington Investment Management Limited 13,399,724 £0
Chelverton Asset Management 12,500,000 £0
RAB Capital 8,750,000 £0
David and Monique Newlands 8,314,815 £0
Newlands Capital 8,314,815 £0
Ali Mortazavi 3,400,000 £0
PARTNERS INVESTMENT COMPANY LLP 3,114,089 £0
Letzone Limited 2,664,000 £0
Beaufort Securities Limited 2,457,568 £0
South Yorkshire Investment Capital Fund LP 1,394,550 £0

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.000p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 0.000p
52 Week Low 0.000p
Volume 0
Shares Issued 2,148.96m

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.79% above the market average13.79% above the market average13.79% above the market average13.79% above the market average13.79% above the market average
90.24% above the sector average90.24% above the sector average90.24% above the sector average90.24% above the sector average90.24% above the sector average
Price Trend
86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average
72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average
Income Not Available
Growth Not Available

Theracryf Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page